[Featured Stock] Humasis Rises Amid Spread of COVID-19 Variants
[Asia Economy Reporter Park Soyeon] Humasis, a company related to diagnostic kits, is showing strong performance amid the increase in COVID-19 cases and the spread of variant viruses.
As of 2 PM on the 23rd, Humasis is trading at 16,900 KRW on the KOSDAQ market, up 3,900 KRW (30%) from the previous day.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
Humasis has a market capitalization of 578.4 billion KRW and ranks 140th on the KOSDAQ. The face value is 100 KRW per share.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
